Compare AURA & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | SMBK |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 797.5M | 893.2M |
| IPO Year | 2021 | 2000 |
| Metric | AURA | SMBK |
|---|---|---|
| Price | $6.04 | $49.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $16.60 | ★ $52.71 |
| AVG Volume (30 Days) | ★ 648.1K | 83.0K |
| Earning Date | 11-12-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | ★ 39.25 |
| EPS | N/A | ★ 1.77 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.63 |
| Revenue Next Year | N/A | $9.31 |
| P/E Ratio | ★ N/A | $27.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $33.01 |
| 52 Week High | $9.54 | $54.14 |
| Indicator | AURA | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 37.51 |
| Support Level | $6.05 | $40.28 |
| Resistance Level | $6.27 | $53.03 |
| Average True Range (ATR) | 0.29 | 1.03 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 24.38 | 17.66 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.